Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus : A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Cardiovascular Diabetology Volume 13 Issue 1
Page 65-
published_at 2014-03-28
Title
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus : A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Creators
Kaku Kohei
Creators
Watada Hirotaka
Creators
Iwamoto Yasuhiko
Creators
Utsunomiya Kazunori
Creators
Terauchi Yasuo
Creators
Tobe Kazuyuki
Creators
Araki Eiichi
Creators
Ueda Masamichi
Creators
Suganami Hideki
Creators
Watanabe Daisuke
Creator Keywords
SGLT2 inhibitor
Tofogliflozin
CSG452
RG7201
HbA_1c
Body weight
Languages
eng
Resource Type
journal article
Publishers
BioMed Central
Date Issued
2014-03-28
File Version
Not Applicable (or Unknown)
Access Rights
metadata only access
Relations
[ISSN]1475-2840
[NCID]AA12050431
[PMID]info:pmid/24678906
[isVersionOf]
[URI]http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=107&action=archive
Schools
大学院医学系研究科（医学）